Moderna faces new lawsuit over lucrative coronavirus vaccine; The Washington Post, February 28, 2022

Yasmeen Abutaleb and Christopher Rowland, The Washington Post; Moderna faces new lawsuit over lucrative coronavirus vaccine

"Moderna faces yet another patent challenge over its coronavirus vaccine after Arbutus Biopharma and Genevant Sciences, both small biotechnology companies, filed a lawsuit on Monday alleging Moderna hijacked its technology to develop the multibillion-dollar vaccine."